AND

are pleased to offer

The Second Annual UCHMC Research Symposium

Date: September 15th 2017

Location:

University of California, San Francisco

Mission Bay Campus, Byers Auditorium

600 16th Street, San Francisco, CA 94158

 

       I.          Course Description

 

The 2nd Annual UCHMC Research Symposium will include discussions on the use of MRD in clinical decision making, opportunities for collaboration across the UC system, application of novel therapies in hematologic malignancies and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium.


The objectives of this meeting are to gain an understanding of how basic research discoveries are being translated into clinical trials, gain a better understanding of best practice in the management of hematologic malignancies and to become familiar with targeted and immunotherapeutic approaches for the treatment of hematologic malignancies.
Physicians, mid-level practitioners, clinical trials staff, fellows, students, basic and translational scientists are encouraged to attend and participate. We are hopeful that this meeting will help (1) patients receive effective treatments, (2) develop innovative clinical trials and (3) spur new translational laboratory investigations within the UC system.

     II.          Target Audience

This course is designed for health care professionals that treat patients with hematologic malignancies, primary care physicians, nurse practitioners, Physician assistants, nurses, registered Pharmacists, and scientists/researchers.

      III.          Learning Objectives

At the completion of the conference participants should be able to:

·      Discuss basic research discoveries are being translated into clinical trials.

·      Describe best practice in the management of hematologic malignancies including appropriate use of MRD testing.

·      Interpret targeted and immunotherapeutic approaches for the treatment of hematologic malignancies.

 

       IV.          Planning Committee & Faculty/Presenter List

University of California Hematologic Malignancies Steering Committee:

Matthew Wieduwilt, MD, PhD

Assistant Clinical Professor of Medicine

Chair, University of California Hematologic Malignancies Consortium

UC San Diego Health, Department of Medicine

Division of Blood and Marrow Transplantation, UCSD Moores Cancer Center

 

Lloyd Damon, MD

Clinical Professor, Department of Medicine, UCSF

Director, Hematologic Malignancies and Bone Marrow Transplant

University of California, San Francisco

 

Joseph Tuscano, MD

Professor

Hematology and Oncology

UC Davis Comprehensive Cancer Center

 

Deepa Jeyakumar, MD

Assistant Clinical Professor

Division of Hematology/Oncology

University of California, Irvine

 

V. CME Credit will be Available

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of UCSF and the University of California Hematologic Malignancies Consortium.  UCSF is accredited by the ACCME to provide continuing medical education for physicians